Evolutionary dynamics of neoantigens in growing tumors.
View/ Open
Date
2020-10-01Author
Lakatos, E
Williams, MJ
Schenck, RO
Cross, WCH
Househam, J
Zapata, L
Werner, B
Gatenbee, C
Robertson-Tessi, M
Barnes, CP
Anderson, ARA
Sottoriva, A
Graham, TA
Type
Journal Article
Metadata
Show full item recordAbstract
Cancers accumulate mutations that lead to neoantigens, novel peptides that elicit an immune response, and consequently undergo evolutionary selection. Here we establish how negative selection shapes the clonality of neoantigens in a growing cancer by constructing a mathematical model of neoantigen evolution. The model predicts that, without immune escape, tumor neoantigens are either clonal or at low frequency; hypermutated tumors can only establish after the evolution of immune escape. Moreover, the site frequency spectrum of somatic variants under negative selection appears more neutral as the strength of negative selection increases, which is consistent with classical neutral theory. These predictions are corroborated by the analysis of neoantigen frequencies and immune escape in exome and RNA sequencing data from 879 colon, stomach and endometrial cancers.
Collections
Subject
Lymphocytes, Tumor-Infiltrating
Humans
Neoplasms
Antigens, Neoplasm
Immunity, Cellular
Mutation
Models, Theoretical
Selection, Genetic
Exome
Clonal Evolution
Whole Exome Sequencing
Language
eng
Date accepted
2020-07-06
License start date
2020-10
Citation
Nature genetics, 2020, 52 (10), pp. 1057 - 1066
Publisher
NATURE PORTFOLIO